# Efficacy and Safety Study Comparing CPL409116 to Placebo in Participants With Active Rheumatoid Arthritis

> **NCT05374785** · PHASE2 · COMPLETED · sponsor: **Celon Pharma SA** · enrollment: 106 (actual)

## Conditions studied

- Rheumatoid Arthritis

## Interventions

- **DRUG:** CPL409116
- **OTHER:** Placebo

## Key facts

- **NCT ID:** NCT05374785
- **Lead sponsor:** Celon Pharma SA
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2022-05-01
- **Primary completion:** 2024-05-27
- **Final completion:** 2024-05-27
- **Target enrollment:** 106 (ACTUAL)
- **Last updated:** 2025-01-23

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05374785

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05374785, "Efficacy and Safety Study Comparing CPL409116 to Placebo in Participants With Active Rheumatoid Arthritis". Retrieved via AI Analytics 2026-07-19 from https://api.ai-analytics.org/clinical/NCT05374785. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*